Brief: Kopran Says USFDA Approved Drug Master File Of Atenolol
18/06/2020 09:19
June 18 (Reuters) - Kopran Ltd KPRN.NS :
* USFDA APPROVED DRUG MASTER FILE OF ATENOLOL
* CO CAN COMMENCE SUPPLIES OF API ATENOLOL TO U.S. MARKET
Source text for Eikon: ID:nBSE29YRCK
Further company coverage: KPRN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kopran
See all newsIndia's Kopran rises as quarterly profit nearly doubles
Brief: Kopran March-Quarter Consol Net Profit 188.7 Million Rupees
Brief: Kopran Flags Cyber-Attack At Its Khopoli Factory
Brief: Kopran Dec-Quarter Consol Profit 93.4 Million Rupees
Brief: Kopran Says Maharashtra Tax Authorities Initiate Search At Mumbai Office